paroxetine has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dayag, M; Gil-Ad, I; Levkovitz, Y; Weizman, A; Zeldich, E | 1 |
| Eglen, RM; Loury, DN; Michel, AD; Sharif, NA; Stefanich, E; Whiting, RL; Wong, EH | 1 |
2 other study(ies) available for paroxetine and Neuroblastoma
| Article | Year |
|---|---|
Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement.
Topics: Animals; Antidepressive Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Mianserin; Mice; Neuroblastoma; Neurons; Paroxetine; Rats | 2005 |
Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Topics: Animals; Binding, Competitive; Cell Line; Cerebral Cortex; Imidazoles; Indoles; Kinetics; Ligands; Mice; Nervous System Neoplasms; Neuroblastoma; Paroxetine; Piperidines; Quipazine; Rats; Receptors, Serotonin; Serotonin Antagonists; Tumor Cells, Cultured | 1991 |